Date of report 20 Jul 2021
Reported case interaction between
Ritonavir and Anabolic steroids/Androgen agonists
Ritonavir and Anabolic steroids/Androgen agonists
Drugs suspected to be involved in the DDI
Perpetrator
Ritonavir
Daily Dose
100
(mg)
Dose adjustment performed
No
Administration Route
Oral
Start date
Unknown
End date
April 27, 2021
Victim
Anabolic steroids/Androgen agonists
Daily Dose
Unknown
Dose adjustment performed
No
Administration Route
Oral
Start date
April 13, 2021
End date
April 28, 2021
Complete list of drugs taken by the patient
Antiretroviral treatment
Raltegravir
Tenofovir-DF
Darunavir (with Ritonavir or Cobicistat)
Complete list of all comedications taken by the patient, included that involved in the DDI
Osta Max bodybuilding supplement (Ostarine)
Clinical case description
Gender
Male
Age
45
eGFR (mL/min)
>60
Liver function impairment
No
Description
Acute drug-induced liver injury (DILI), with ALT rising to >1500, AST to 181 IU/L. Liver function tests normalized after discontinuing Osta Max. Osta Max contains ostarine- a selective androgen receptor modulator, which is a UGT and CYP 3a substrate.
Clinical Outcome
Toxicity
Drug Interaction Probability Scale (DIPS)
Score
8 - Probable
Editorial Comment
Ostarine is a UGT and CYP 3a substrate. Inhibition of CYPs by RTV may increase the risk of drug-induced liver injury, as it happened in this patient.
University of Liverpool Recommendation
N/A